TapewireFind a company

person · Reporting owner

MESSEMER DEBORAH M.

Disclosed activity across 3 companies

Tapewire entity
29667
SEC CIK
0001754424

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Allogene Therapeutics, Inc.ALLO · Entity 5243DirectorJune 18, 2026June 23, 2026
PayPal Holdings, Inc.PYPL · Entity 2530DirectorMay 19, 2026May 20, 2026
TPG Inc.TPG · Entity 3253DirectorJuly 15, 2026July 17, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Allogene Therapeutics, Inc.

Report date June 18, 2026 · Filed June 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitSEC Table II · derivative / convertible securityDirect95,400 Reported balance After 2026-06-18 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-18 · Grant · Acquired 95,400 · Balance 95,400

F1: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

PayPal Holdings, Inc.

Report date May 19, 2026 · Filed May 20, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect20,251 Reported balance After 2026-05-19 transaction · row 1
1 source row

Row 1 · 2026-05-19 · Grant · Acquired 6,275 · Balance 20,251

F1: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

TPG Inc.

Report date July 15, 2026 · Filed July 17, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect20,988 Reported balance After 2026-07-15 transaction · row 1
1 source row

Row 1 · 2026-07-15 · Grant · Acquired 4,181 · Balance 20,988

F1: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 15, 2026 Filed Jul 17, 2026 21:24 UTC TPG Inc. TPG · Entity 3253 GrantClass A Common Stock 4,181 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-26-000711 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,988

F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Read SEC document
June 18, 2026 Filed Jun 23, 2026 20:34 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantRestricted Stock Unit · Derivative 95,400 $0.00 $0.00
Disclosure

SEC source: 0001737287-26-000021 · wk-form4_1782246849.xml · derivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,400

Underlying: Common Stock · 95,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

F1 · derivative.exercise_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

F1 · derivative.expiration_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

Read SEC document
May 19, 2026 Filed May 20, 2026 23:02 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 6,275 $0.00 $0.00
Disclosure

SEC source: 0001754424-26-000002 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,251

F1 · shares: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 23:34 UTC TPG Inc. TPG · Entity 3253 SaleClass A Common Stock 1,796 $56.32 $101,148.39
Disclosure

SEC source: 0000947871-25-000674 · ownership.xml · nonDerivative · entry 2

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,807

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock were sold in multiple transactions at prices ranging from $56.14 to $56.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 23:34 UTC TPG Inc. TPG · Entity 3253 GrantClass A Common Stock 2,762 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-25-000674 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,603

F1 · shares: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock ("Class A common stock") of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock ("Class A common stock") of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Read SEC document
June 18, 2025 Filed Jun 24, 2025 01:03 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantRestricted Stock Unit · Derivative 95,400 $0.00 $0.00
Disclosure

SEC source: 0001737287-25-000076 · wk-form4_1750727027.xml · derivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,400

Underlying: Common Stock · 95,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.

F1 · derivative.exercise_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.

F1 · derivative.expiration_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Ms. Messemer has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:18 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 SaleCommon Stock 36,885 $1.42 $52,376.70
Disclosure

SEC source: 0001737287-25-000066 · wk-form4_1749759007.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,431

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $1.38 to $1.445, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
June 06, 2025 Filed Jun 7, 2025 00:03 UTC PayPal Holdings, Inc. PYPL · Entity 2530 SaleCommon Stock 3,795 $73.00 $277,036.14
Disclosure

SEC source: 0001633917-25-000097 · edgardoc.xml · nonDerivative · entry 2

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,976

Read SEC document
June 05, 2025 Filed Jun 7, 2025 00:03 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 3,795 $0.00 $0.00
Disclosure

SEC source: 0001633917-25-000097 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,771

F1 · shares: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
February 18, 2025 Filed Feb 20, 2025 21:15 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 SaleCommon Stock 13,313 $2.43 $32,350.59
Disclosure

SEC source: 0001737287-25-000022 · wk-form4_1740086122.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,316

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/30/2024.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $2.42 to $2.44, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
January 14, 2025 Filed Jan 15, 2025 22:36 UTC TPG Inc. TPG · Entity 3253 SaleClass A Common Stock 1,695 $61.91 $104,930.67
Disclosure

SEC source: 0000947871-25-000042 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,841

F1 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock of TPG Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $61.73 to $62.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 21:53 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 SaleCommon Stock 9,136 $2.18 $19,916.48
Disclosure

SEC source: 0001737287-24-000081 · wk-form4_1733867628.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,629

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.16 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
July 17, 2024 Filed Jul 17, 2024 21:37 UTC TPG Inc. TPG · Entity 3253 SaleClass A Common Stock 4,089 $46.55 $190,331.91
Disclosure

SEC source: 0000947871-24-000625 · ownership.xml · nonDerivative · entry 2

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,536

F2 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock of the Issuer were sold in multiple transactions at prices ranging from $45.94 to $46.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 21:37 UTC TPG Inc. TPG · Entity 3253 GrantClass A Common Stock 3,592 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-24-000625 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,625

F1 · shares: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Read SEC document
June 18, 2024 Filed Jun 20, 2024 20:31 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 SaleCommon Stock 18,641 $2.28 $42,488.43
Disclosure

SEC source: 0001593968-24-000878 · primary_01.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,765

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:25 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantCommon Stock 122,950 $0.00 $0.00
Disclosure

SEC source: 0001593968-24-000835 · primary_01.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,406

Read SEC document
May 24, 2024 Filed May 24, 2024 21:09 UTC PayPal Holdings, Inc. PYPL · Entity 2530 SaleCommon Stock 4,422 $61.65 $272,616.30
Disclosure

SEC source: 0001633917-24-000070 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,976

Read SEC document
May 22, 2024 Filed May 24, 2024 01:27 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 4,422 $0.00 $0.00
Disclosure

SEC source: 0001633917-24-000064 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,398

F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 22:14 UTC TPG Inc. TPG · Entity 3253 SaleClass A Common Stock 6,390 $43.97 $280,980.44
Disclosure

SEC source: 0000947871-24-000242 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,033

F1 · price: The price reported in Column 4 is a weighted average price. These shares of Class A common stock of TPG Inc. (the 'Issuer") were sold in multiple transactions at prices ranging from $43.47 to $44.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 21:26 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 SaleCommon Stock 18,640 $2.70 $50,316.82
Disclosure

SEC source: 0001593968-23-001520 · primary_01.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,456

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/29/2023

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
July 15, 2023 Filed Jul 18, 2023 20:12 UTC TPG Inc. TPG · Entity 3253 GrantClass A Common Stock 5,111 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-23-000757 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,423

F1 · shares: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

F1 · price: Represents an annual award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs will vest on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Read SEC document
June 13, 2023 Filed Jun 15, 2023 21:06 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantCommon Stock 74,561 $0.00 $0.00
Disclosure

SEC source: 0001593968-23-001013 · primary_01.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,096

Read SEC document
May 24, 2023 Filed May 26, 2023 23:14 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 4,450 $0.00 $0.00
Disclosure

SEC source: 0001633917-23-000095 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,976

F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
July 15, 2022 Filed Jul 19, 2022 21:08 UTC TPG Inc. TPG · Entity 3253 GrantRestricted Stock Units 9,142 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-22-000790 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,312

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). The Issuer has granted the RSUs pursuant to its Independent Director Compensation Policy. The RSUs represent an annual award that vests on the first anniversary of the grant date, subject to the Reporting Person's continuous service through the vesting date; provided that if the Reporting Person serves through the Issuer's next annual meeting of shareholders occurring after the date of grant, the Reporting Person will be entitled to retain the RSUs.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:57 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantStock Option (Right to Buy) · Derivative 71,070 $0.00 Strike: $9.62 $0.00
Disclosure

SEC source: 0001214659-22-008166 · marketforms-56488.xml · derivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,070

Underlying: Common Stock · 71,070 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 15, 2022.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 22:23 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 3,114 $0.00 $0.00
Disclosure

SEC source: 0001633917-22-000118 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,526

F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
January 13, 2022 Filed Jan 14, 2022 01:20 UTC TPG Inc. TPG · Entity 3253 GrantRestricted Stock Units 10,170 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-22-000064 · ownership.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,170

F1 · price: Each restricted stock unit (RSU) represents a contingent right to receive one share of Class A common stock of TPG Inc. (the "Issuer"). One-third of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continuous service through the vesting date.

Read SEC document
June 10, 2021 Filed Jun 11, 2021 21:46 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantStock Option (Right to Buy) · Derivative 28,015 $0.00 Strike: $25.76 $0.00
Disclosure

SEC source: 0001214659-21-006502 · marketforms-53109.xml · derivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,015

Underlying: Common Stock · 28,015 shares

Expires 2031-06-10

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 10, 2021.

Read SEC document
May 26, 2021 Filed May 27, 2021 20:50 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 1,053 $0.00 $0.00
Disclosure

SEC source: 0001633917-21-000112 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,412

F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:03 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantStock Option (Right to Buy) · Derivative 16,640 $0.00 Strike: $42.63 $0.00
Disclosure

SEC source: 0001214659-20-005493 · marketforms-49013.xml · derivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,640

Underlying: Common Stock · 16,640 shares

Expires 2030-06-05

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 5, 2020.

Read SEC document
May 21, 2020 Filed May 22, 2020 22:33 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 1,856 $0.00 $0.00
Disclosure

SEC source: 0001633917-20-000115 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,359

F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
June 06, 2019 Filed Jun 25, 2019 00:05 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 GrantStock Option (Right to Buy) · Derivative 26,025 $0.00 Strike: $25.95 $0.00
Disclosure

SEC source: 0001209191-19-038868 · doc4.xml · derivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,025

Underlying: Common Stock · 26,025 shares

Expires 2029-06-06

F1 · derivative.exercise_date: The stock option vests in 12 equal monthly installments beginning July 6, 2019.

Read SEC document
May 22, 2019 Filed May 24, 2019 22:36 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 2,446 $0.00 $0.00
Disclosure

SEC source: 0001633917-19-000150 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,503

F1 · shares: The reporting person has received a fully vested stock payment award for shares of the Company common stock. Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for common stock promptly following the Company's annual meeting of stockholders. The number of shares of common stock granted represents the quotient of (A) $275,000 divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share of common stock.

Read SEC document
January 16, 2019 Filed Jan 18, 2019 22:27 UTC PayPal Holdings, Inc. PYPL · Entity 2530 GrantCommon Stock 1,057 $0.00 $0.00
Disclosure

SEC source: 0001633917-19-000021 · edgardoc.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,057

F1 · shares: Pursuant to the Company's Independent Director Compensation Policy, the reporting person has been granted a fully vested stock payment award for Company common stock promptly following her appointment as a director of the Company. The number of shares of common stock granted represents the quotient of (A) $95,684.93 (representing the amount of the annual equity award (i.e., $275,000), prorated to reflect the number of days from the date of her appointment to the first anniversary of the most recent annual stockholders meeting), divided by (B) the Company's closing stock price on the date of grant, rounded up to the nearest whole share.

Read SEC document
October 15, 2018 Filed Oct 17, 2018 21:33 UTC Allogene Therapeutics, Inc. ALLO · Entity 5243 OtherCommon Stock 6,535 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-18-055391 · doc4.xml · nonDerivative · entry 1

MESSEMER DEBORAH M. · CIK 0001754424 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 6,535

F1 · kind: Automatic conversion of an outstanding convertible promissory note in the principal amount of $100,000 into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering at a conversion price of $15.30 per share.

F1 · price: Automatic conversion of an outstanding convertible promissory note in the principal amount of $100,000 into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering at a conversion price of $15.30 per share.

F2 · ownership.nature: Securities held in the name of the Messemer Family Trust dated February 18, 2003.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.